Immunogenicity 14053
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
NLGN3
Transcript ID
uc011mps.2
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (808 aa)
MWLRL
1
GPPSL
6
SLSPK
11
PTVGR
16
SLCLT
21
LWFLS
26
LALRA
31
STQAP
36
APTVN
41
THFGK
46
LRGAR
51
VPLPS
56
EILGP
61
VDQYL
66
GVPYA
71
APPIG
76
EKRFL
81
PPEPP
86
PSWSG
91
IRNAT
96
HFPPV
101
CPQNI
106
HTAVP
111
EVMLP
116
VWFTA
121
NLDIV
126
ATYIQ
131
EPNED
136
CLYLN
141
VYVPT
146
EDDIR
151
DSGAK
156
PVMVY
161
IHGGS
166
YMEGT
171
GNMID
176
GSILA
181
SYGNV
186
IVITL
191
NYRVG
196
VLGFL
201
STGDQ
206
AAKGN
211
YGLLD
216
QIQAL
221
RWVSE
226
NIAFF
231
GGDPR
236
RITVF
241
GSGIG
246
ASCVS
251
LLTLS
256
HHSEG
261
LFQRA
266
IIQSG
271
SALSS
276
WAVNY
281
QPVKY
286
TSLLA
291
DKVGC
296
NVLDT
301
VDMVD
306
CLRQK
311
SAKEL
316
VEQDI
321
QPARY
326
HVAFG
331
PVIDG
336
DVIPD
341
DPEIL
346
MEQGE
351
FLNYD
356
IMLGV
361
NQGEG
366
LKFVE
371
GVVDP
376
EDGVS
381
GTDFD
386
YSVSN
391
FVDNL
396
YGYPE
401
GKDTL
406
RETIK
411
FMYTD
416
WADRD
421
NPETR
426
RKTLV
431
ALFTD
436
HQWVE
441
PSVVT
446
ADLHA
451
RYGSP
456
TYFYA
461
FYHHC
466
QSLMK
471
PAWSD
476
AAHGD
481
EVPYV
486
FGVPM
491
VGPTD
496
LFPCN
501
FSKND
506
VMLSA
511
VVMTY
516
WTNFA
521
KTGDP
526
NKPVP
531
QDTKF
536
IHTKA
541
NRFEE
546
VAWSK
551
YNPRD
556
QLYLH
561
IGLKP
566
RVRDH
571
YRATK
576
VAFWK
581
HLVPH
586
LYNLH
591
DMFHY
596
TSTTT
601
KVPPP
606
DTTHS
611
SHITR
616
RPNGK
621
TWSTK
626
RPAIS
631
PAYSN
636
ENAQG
641
SWNGD
646
QDAGP
651
LLVEN
656
PRDYS
661
TELSV
666
TIAVG
671
ASLLF
676
LNVLA
681
FAALY
686
YRKDK
691
RRQEP
696
LRQPS
701
PQRGA
706
GAPEL
711
GAAPE
716
EELAA
721
LQLGP
726
THHEC
731
EAGPP
736
HDTLR
741
LTALP
746
DYTLT
751
LRRSP
756
DDIPL
761
MTPNT
766
ITMIP
771
NSLVG
776
LQTLH
781
PYNTF
786
AAGFN
791
STGLP
796
HSHST
801
TRV
806
Mutation Information
DNA mutation:
None
Peptide Range:
684 ~ 708
Mut AA position:
696 (13 in Wild Type peptide)
Alignment
Wild Type:
"LAFAALYYRKDKRRQEPLRQPSPQR
||||||||||||.||||||||||||
Mutant:
LAFAALYYRKDKQRQEPLRQPSPQR"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) NLGN3
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay